6Pena C, Pujol M, Pallares R, et al. Estiamtion of costs attributable to nosocomial infection :prolongation of hospitalization and calculation of ahernative costs [ J ]. Med Clin (Barc), 1996, 106 (12):441.
5[1]American Thoracic Society.Guidelines for the management of adults with community acquired pneumonia[J].Am J Crit Care Med,2001,163(7):1730-1754.
6[2]American Thoracic Society,Infectious Diseases Society of America.Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia[J].Am J Respir Crit Care,2005,171(4):388-416.
7[3]Paganin F,Lilienthal F,Bourdin A,et al.Severe community-acquired pneumonia:assessment of microbial aetiology as mortality factor[J].Eur Respir J,2004,24(5):779-785.
8[4]Rello J,Bodi M,Mariscal D,et al.Microbiological testing and outcome of patients with severe community-acquired pneumonia[J].Chest,2003,123(1):174-180.
9[7]Valles J,Mesalles E,Mariscal D,et al.A 7-year study of severe hospital-acquired pneumonia requiring ICU admission[J].Intensive Care Med,2003,29(11):1981-1988.
10[8]Wilson PA,Ferguson J.Severe community-acquired pneumonia:an Australian perspective[J].Intern Med J,2005,35(12):699-705.
